Share
Share today's newsletter with a colleague and get credit if they sign up for SmartBrief.
Referral Count:
 
0

Story being shared
Roche wins FDA OK for wider use of flu drug Tamiflu
The FDA endorsed the use of Roche Holding's flu treatment Tamiflu, or oseltamivir, for children ages 2 weeks to 1 year who have had symptoms of flu for no more than two days. The drug is not indicated for flu prevention in this age group, according to the agency.

Or we can send an email on your behalf
You must submit valid email addresses only. Use of email addresses is subject to terms of SmartBrief's privacy policy .